{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/EPP"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"EPP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","market":"US","secType":"STK","nameCN":"iShares MSCI Pacific ex Japan ETF","latestPrice":40.19,"timestamp":1743796800000,"preClose":43.78,"halted":0,"volume":1392609,"hourTrading":{"tag":"盘后","latestPrice":40.19,"preClose":40.19,"latestTime":"16:05 EDT","volume":3,"amount":120.57,"timestamp":1743797108167},"delay":0,"floatShares":41400000,"shares":41400000,"eps":6.184397,"marketStatus":"Market Closed","change":-3.59,"latestTime":"04-04 16:00:00 EDT","open":41.26,"high":41.5,"low":39.89,"amount":56357068.5545,"amplitude":0.036775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":6.184397,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":43.78,"sharesOutstanding":41400000,"nav":43.877674,"aum":1816535704,"dividendRate":0.041486,"bidAskSpread":0.000571,"preHourTrading":{"tag":"盘前","latestPrice":41.68,"preClose":43.78,"latestTime":"07:07 EDT","volume":2479,"amount":104154.718948,"timestamp":1743764844679},"postHourTrading":{"tag":"盘后","latestPrice":40.19,"preClose":40.19,"latestTime":"16:05 EDT","volume":3,"amount":120.57,"timestamp":1743797108167},"volumeRatio":5.820844052361861,"impliedVol":0.0791,"impliedVolPercentile":0.6016},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EPP\",,,,,undefined,":{"symbol":"EPP","floatShares":41400000,"roa":"2.21%","roe":"14.00%","lyrEps":6.184397,"volumeRatio":5.820844052361861,"shares":41400000,"dividePrice":1.667309,"high":41.5,"amplitude":0.036775,"preClose":43.78,"low":39.89,"week52Low":39.89,"pbRate":"0.84","psRate":"21.59","week52High":49.29,"institutionHeld":0,"latestPrice":40.19,"eps":6.184397,"divideRate":0.041486,"volume":1392609,"delay":0,"ttmEps":6.184397,"open":41.26,"prevYearClose":43.81,"prevWeekClose":44.25,"prevMonthClose":44.1,"prevQuarterClose":44.1,"fiveDayClose":44.25,"twentyDayClose":45.12,"sixtyDayClose":44.18},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/EPP\",params:#limit:6,delay:false,,,undefined,":[{"market":"US","name":"ESG ETF-MSCI","bkCode":"BK4582","id":"package_us_concept_esgetfmsci","changeRate":-0.047001}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"EPP\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2524127657","title":"Biocurious: While other biotechs scratch around for cash, Clinuvel is accused of having too much","url":"https://stock-news.laohu8.com/highlight/detail?id=2524127657","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524127657?lang=en_us&edition=fundamental","pubTime":"2025-04-02 04:00","pubTimestamp":1743537645,"startTime":"0","endTime":"0","summary":"Some investors contend Clinuvel’s mountain of $200 million of cash is excessive and amounts to a ‘lazy’ balance sheet. The company argues the cash buffer protects it against unexpected adversities and – in any event – every cent will be needed for clinical trials. Clinuvel highlights the divide between the sector’s cash have-nots and have-lots. Corporate investor briefings are normally civil affairs, but in the case of skin disorders specialist Clinuvel Pharmaceuticals  a recent powwow turned tetchy for a most unusual reason.The point of contention?","market":"hk","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-77130653-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/04/GettyImages-77130653-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/biocurious-while-other-biotechs-scratch-around-for-cash-clinuvel-is-accused-of-having-too-much/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["BK4582","EPP"],"gpt_icon":0},{"id":"2516692071","title":"Clinuvel Introduces Groundbreaking Vitiligo Program at the World’s Biggest Dermatology Meeting, AAD 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516692071","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516692071?lang=en_us&edition=fundamental","pubTime":"2025-03-04 10:17","pubTimestamp":1741054620,"startTime":"0","endTime":"0","summary":"MELBOURNE, Australia, March  03, 2025  (GLOBE NEWSWIRE) -- World-leading photomedicine company CLINUVEL will make its début at the American Academy of Dermatology (AAD) Annual Meeting from March 7–11,","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/03/04/3036144/0/en/Clinuvel-Introduces-Groundbreaking-Vitiligo-Program-at-the-World-s-Biggest-Dermatology-Meeting-AAD-2025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPP","BK4582"],"gpt_icon":0},{"id":"2514791801","title":"Press Release: Disc Medicine Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2514791801","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514791801?lang=en_us&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661200,"startTime":"0","endTime":"0","summary":"-- Targeting NDA submission for bitopertin in erythropoietic protoporphyria.  in H2 2025 through accelerated approval pathway; on track to. -- Positive update from Phase 1b trial of DISC-0974 in patients with anemia. of myelofibrosis  presented at ASH 2024; initial data from ongoing. -- Positive data from initial cohorts of ongoing Phase 1b study of DISC-0974. in patients with anemia of non-dialysis-dependent chronic kidney disease.  presented at ASN Kidney Week 2024; initial data from multiple. -- Presented first-in-human SAD/MAD data from Phase 1 trial of DISC-3405. demonstrating proof-of-mechanism; a Phase 2 study in polycythemia vera. -- Strong financial position ending 2024 with $490 million in cash, cash. equivalents, and marketable securities, further strengthened by the net. proceeds of our public offering in January 2025, expected to fund. WATERTOWN, Mass., Feb. 27, 2025  -- Disc Medicine, Inc. , a clinical-stage biopharmaceutical company focused on the discovery, development,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4582","IRON","EPP","BK4139"],"gpt_icon":0},{"id":"2510600654","title":"Health Check: Ansell gloves up for Trump tariff threat","url":"https://stock-news.laohu8.com/highlight/detail?id=2510600654","media":"Stockheads","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510600654?lang=en_us&edition=fundamental","pubTime":"2025-02-10 10:48","pubTimestamp":1739155692,"startTime":"0","endTime":"0","summary":"Ansell is expanding its manufacturing to be less reliant on China. Mayne Pharma pre-announces a strong first-half earnings recovery. Alterity Therapeutics raises $40 million on the back of encouraging trial","market":"us","thumbnail":"https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-1221546666-1200x675-1-640x360.jpg","type":0,"news_type":0,"thumbnails":["https://stockhead.com.au/wp-content/uploads/2025/02/GettyImages-1221546666-1200x675-1-640x360.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stockhead.com.au/health/health-check-ansell-gloves-up-for-trump-tariff-threat/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockheads_stock","symbols":["LU2125909916.SGD","LU2125909759.SGD","LU1923622291.USD","EPP","LU2211815571.USD","BK4143","LU0757428866.USD","LU0728928796.USD","MSA","LU1815336091.USD","LU0053671581.USD","BK4582"],"gpt_icon":0}],"pageSize":4,"totalPage":7,"pageCount":1,"totalSize":25}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EPP\",params:#limit:5,,,undefined,":[{"date":"2024-12-17","symbol":"EPP","amount":0.96746,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2024-06-11","symbol":"EPP","amount":0.70131,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-11","defaultRemindTime":1718112600000,"name":"亚太地区（除日本）ETF-iShares MSCI","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-17","payableDate":"2024-06-11","currency":"USD","dateTimestamp":1718078400000,"payDate":"2024-06-17"},{"date":"2023-12-20","symbol":"EPP","amount":0.966028,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"亚太地区（除日本）ETF-iShares MSCI","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"EPP","amount":0.814552,"announcedDate":"2023-06-06","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"亚太地区（除日本）ETF-iShares MSCI","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"},{"market":"US","date":"2022-12-13","symbol":"EPP","amount":0.70879,"defaultRemindTime":1670941800000,"name":"亚太地区（除日本）ETF-iShares MSCI","recordDate":"2022-12-19","payableDate":"2022-12-14","currency":"USD","type":"dividend","dateTimestamp":1670907600000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EPP\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-25","recordDate":"2015-06-29","paymentDate":"2015-07-01","value":0.952237,"currency":"USD"},{"executeDate":"2015-12-21","recordDate":"2015-12-23","paymentDate":"2015-12-28","value":0.927279,"currency":"USD"},{"executeDate":"2016-06-22","recordDate":"2016-06-24","paymentDate":"2016-06-28","value":0.661333,"currency":"USD"},{"executeDate":"2016-12-21","recordDate":"2016-12-23","paymentDate":"2016-12-28","value":0.90607,"currency":"USD"},{"executeDate":"2017-06-20","recordDate":"2017-06-22","paymentDate":"2017-06-26","value":0.756156,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EPP\",market:\"US\",delay:false,,,undefined,":{}}}